OPRX News and Press, OptimizeRx Corporation From 02/25/21

Because of COVID-19, investors in Moderna (NASDAQ: MRNA) , Teladoc Health (NYSE: TDOC) , and Fulgent Genetics (NASDAQ: FLGT) have had amazing returns over the last year. Is the virus going away soon? Will these stocks crash when it does? Healthcare and Cannabis Burea...

Image source: The Motley Fool. OPTIMIZERX CORP (NASDAQ: OPRX) Q4 2020 Earnings Call Feb 24, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: OPTIMIZERX CORP (OPRX) Q4 2020 Earnings Call Transcript

OptimizeRx Corporation. (OPRX) Q4 2020 Results Earnings Conference Call February 24, 2021, 4:30 PM ET Company Participants William Febbo - Chief Executive Officer Doug Baker - Chief Financial Officer Stephen Silvestro - Chief Commercial Officer Miriam Paramore - President Conference Call Part...

ROCHESTER, Mich., Feb. 24, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, reported results for the fourth quarter and full year ended December 31, 2020. Quarterly and full ...

ROCHESTER, Mich., Feb. 23, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced its senior vice president and principal of agency channels, Angelo Campano , has been ...

ROCHESTER, Mich., Feb. 18, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hold a conference call on Wednesday, February 24, 2021 at 4:30 p.m. Eastern time to discuss its...

OptimizeRx (NASDAQ: OPRX) is a tiny small-cap that is still under $1 billion in valuation. But it probably won't stay there for long. Shares of this pharmaceutical marketing company have been soaring, running up nearly 450% over the last 12 months. And another fast-growing healthcar...

ROCHESTER, Mich., Feb. 16, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has been invited to present at the SVB Leerink 10 th Annual Global Healthcare Conference bei...

OptimizeRx (OPRX) priced its earlier announced underwritten public offering of 1.33M shares at $49.5/share; underwriters granted 30-day option to purchase up to an additional 198,750 shares.Gross proceeds are expected to be ~$65.6M.Proceeds to be used for general corporate purposes, which may...

OptimizeRx (OPRX) announces that it has commenced an underwritten public offering of shares.The company is expected to grant the underwriters a 30-day option to purchase up to an additional 15% of shares.The net proceeds of the offering will be used for general corporate purposes, which may i...